China
Africa
Explore chapters and articles related to this topic
Medical Tourism And Well-Being: Trends and Strategies
Published in Frederick J. DeMicco, Ali A. Poorani, Medical Travel Brand Management, 2023
Frederick J. DeMicco, M. Cetron, O. Davies
Now consider Europe and, to a lesser extent, the U.S. and Canada. They are well supplied with skilled doctors and high-quality hospitals, and patients in Europe and Canada are covered by government-supported medical systems. In the U.S., we believe the long-term trend leads to the establishment of a single-payer healthcare system, but only after further delay by politically powerful lobbies. Until then, care will remain expensive and insurance coverage spotty. In the UK and Canada especially, even urgently needed treatment can be delayed by shortages of capacity and other factors.
Healthcare Politics and Policy in America
Published in Kant Patel, Mark Rushefsky, Healthcare Politics and Policy in America, 2019
Scott (2018b) points out the political implications of the analyses. For conservatives such as Blahous (2018), the new numbers are very high, and the role of government would expand, all good political talking points. For liberals, advocates of single-payer healthcare, the key is to emphasize that Americans as whole will save money.
Health Care Systems and Health Policy: Effects on Health Outcomes
Published in Deborah Fish Ragin, Health Psychology, 2017
Publicly sponsored and funded plans are also called single-payer plans because one agency, in this case, the U.S. government, provides the sole financial support. For the moment, it is important to note that in all other developed countries, including Canada, England, France, and Sweden, a single-payer health care model is the norm for the majority of the populations. Although private insurers also offer health insurance in these countries, the vast majority of people in the industrialized countries mentioned previously and others rely on the government-sponsored managed-care plans for their primary source of care. We discuss the single-payer system in the section on health policy later in the chapter.
Bioethics Advocacy in Ethos, Practice and Metrics
Published in The American Journal of Bioethics, 2021
Amelia K. Barwise, Bjoerg Thorsteinsdottir, Megan A. Allyse, Michelle J. Clarke, Karen M. Meagher
Deciding to prioritize issues of access and justice in healthcare is not new in bioethics, but rather a reinvigoration of foundational topics in light of past failures (Mithani et al. 2020). Combined with this renewed interest can be a commitment to embrace the practical implications of our analyses, including responsibilities to support clinical colleagues in realizing a more just healthcare system. Notably, there has been a concurrent political shift over the past few decades among physicians toward more focus on societal good. This is reflected in many professional organization position statements, with some even calling for single payer healthcare, previously unthinkable in the US context. Initial opposition to the ACA among many physicians has decreased significantly as they have witnessed first-hand the benefits for patients (Riordan et al. 2019).
“Formulating a New Healthcare System with Old Ideals: America’s Next Step”
Published in Hospital Topics, 2020
Matthew R. Wolek, Robert J. Spinelli
Single-payer health care systems are some of the most successful health care systems in the world in terms of cost and health outcomes. The premise of a single-payer system is that health care is paid for by one entity. Essentially, everyone would be under the same insurance plan. This could be achieved multiple ways by just filling in the holes not covered by Medicare and Medicaid with employer coverage and the individual market (Wharton 2017). This would work, but it would be confusing to many people. Most single-payer systems are covered through a public insurance system, such as that of Canada and the U.K., but that doesn’t mean the government runs the facilities. Everyone at least gets a basic level of care in a single-payer system (Luthra 2017). Insurance sometimes won’t cover prescription meds, dental and eye care, or some specialty care. In this instance, people may opt to by additional private insurance to cover those costs. Much of the funding for hospitals and clinics would come from governments, which would set prices for drugs and procedures that the practices can’t exceed (Ridic, Gleason, and Ridic 2012). One of the most fundamental parts of a single-payer system is that the countries that use it believe that health care for its citizens is a right, not a privilege that needs to be bought (Luthra 2017).
Trends in Survival Based on Treatment Modality in Non-Small Cell Lung Cancer Patients: A Population-Based Study
Published in Cancer Investigation, 2019
Noori Akhtar-Danesh, Gileh-Gol Akhtar-Danseh, Hsien Yeang Seow, Saad Shakeel, Christian Finley
This study has several limitations. First, incomplete submission of cancer staging data for all patients diagnosed with NSCLC in Ontario limited our ability to analyze the entire cohort between 2007 and 2015. Second, besides sex, age, stage, histology of tumor, various other factors could be involved in treatment decisions (e.g. comorbidity and patient preferance) that could not be captured using administrative datasets. Third, this study is susceptible to coding and recording error, a limitation inherent to most studies conducted with administrative datasets. Fourth, this study was conducted within a single-payer healthcare system in Ontario and its findings may not be generalizable to private healthcare systems. The treatment effects of radiation, chemotherapy, and surgery in patients with lung cancer can be hypothesized to differ in multi-payer systems, and the results of this study should therefore be taken in context of a universal healthcare system. Finally, this is a retrospective observational study where a treatment plan was usually decided based on clinical judgment or an existing medical guideline. Due to the complicated decision-making process, the treatment selection bias would be substantial in this retrospective study. Therefore, the findings should be used to illustrate the trend of survival rate over time, not to judge which treatment modality is superior.